Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 6.45471984 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 6.45471984 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.39354025 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.39354025 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68620313 |
6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.49188155 |
7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.35007144 |
8 | protein retention in ER lumen (GO:0006621) | 4.14157122 |
9 | barbed-end actin filament capping (GO:0051016) | 3.89611976 |
10 | signal peptide processing (GO:0006465) | 3.61278010 |
11 | skin morphogenesis (GO:0043589) | 3.51005990 |
12 | adhesion of symbiont to host (GO:0044406) | 3.50502252 |
13 | regulation of early endosome to late endosome transport (GO:2000641) | 3.41557580 |
14 | basement membrane organization (GO:0071711) | 3.33217584 |
15 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.21789155 |
16 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17475530 |
17 | pinocytosis (GO:0006907) | 3.15931882 |
18 | stress fiber assembly (GO:0043149) | 3.15777258 |
19 | protein maturation by protein folding (GO:0022417) | 3.14666260 |
20 | peptide hormone processing (GO:0016486) | 3.04754851 |
21 | positive regulation of nuclease activity (GO:0032075) | 3.01155828 |
22 | vesicle coating (GO:0006901) | 2.97670676 |
23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.94598564 |
24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93547306 |
25 | response to laminar fluid shear stress (GO:0034616) | 2.92905807 |
26 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.91523653 |
27 | apoptotic cell clearance (GO:0043277) | 2.91357568 |
28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.88540745 |
29 | endodermal cell differentiation (GO:0035987) | 2.86984106 |
30 | cell-substrate junction assembly (GO:0007044) | 2.86314176 |
31 | hyaluronan catabolic process (GO:0030214) | 2.84002814 |
32 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82981276 |
33 | positive regulation of extracellular matrix organization (GO:1903055) | 2.82263839 |
34 | glycosphingolipid catabolic process (GO:0046479) | 2.79079499 |
35 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.79066527 |
36 | synaptic vesicle maturation (GO:0016188) | 2.77328468 |
37 | adherens junction assembly (GO:0034333) | 2.77027107 |
38 | COPII vesicle coating (GO:0048208) | 2.74822681 |
39 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.74611482 |
40 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.72935926 |
41 | regulation of nuclease activity (GO:0032069) | 2.71617618 |
42 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71602912 |
43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.71535999 |
44 | regulation of beta-amyloid formation (GO:1902003) | 2.71393326 |
45 | cell adhesion mediated by integrin (GO:0033627) | 2.69477352 |
46 | hemidesmosome assembly (GO:0031581) | 2.68722925 |
47 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.68585020 |
48 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.67746175 |
49 | low-density lipoprotein particle clearance (GO:0034383) | 2.67216256 |
50 | focal adhesion assembly (GO:0048041) | 2.66992851 |
51 | cell-substrate adherens junction assembly (GO:0007045) | 2.66992851 |
52 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65947172 |
53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.65527629 |
54 | mannose metabolic process (GO:0006013) | 2.64682585 |
55 | cellular response to unfolded protein (GO:0034620) | 2.64590471 |
56 | negative regulation of cell size (GO:0045792) | 2.64022010 |
57 | positive regulation of receptor recycling (GO:0001921) | 2.63342762 |
58 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.62637438 |
59 | epithelial cell-cell adhesion (GO:0090136) | 2.62033812 |
60 | negative regulation of fatty acid transport (GO:2000192) | 2.61487258 |
61 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.60896209 |
62 | proline biosynthetic process (GO:0006561) | 2.60779399 |
63 | protein heterotrimerization (GO:0070208) | 2.60391870 |
64 | peptidyl-proline hydroxylation (GO:0019511) | 2.59585645 |
65 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59061460 |
66 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.58630814 |
67 | modulation by symbiont of host cellular process (GO:0044068) | 2.58314910 |
68 | regulation of cholesterol homeostasis (GO:2000188) | 2.56955191 |
69 | negative thymic T cell selection (GO:0045060) | 2.56784696 |
70 | negative T cell selection (GO:0043383) | 2.55610094 |
71 | glucose 6-phosphate metabolic process (GO:0051156) | 2.55477369 |
72 | ER-nucleus signaling pathway (GO:0006984) | 2.54874415 |
73 | positive regulation of vesicle fusion (GO:0031340) | 2.54869538 |
74 | activation of MAPKKK activity (GO:0000185) | 2.53784312 |
75 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53710691 |
76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.51692058 |
77 | glycolipid catabolic process (GO:0019377) | 2.51526422 |
78 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51366427 |
79 | activation of protein kinase A activity (GO:0034199) | 2.51357447 |
80 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51297417 |
81 | cellular response to topologically incorrect protein (GO:0035967) | 2.51232808 |
82 | semaphorin-plexin signaling pathway (GO:0071526) | 2.50212530 |
83 | embryo implantation (GO:0007566) | 2.50075090 |
84 | NIK/NF-kappaB signaling (GO:0038061) | 2.48328330 |
85 | apoptotic process involved in morphogenesis (GO:0060561) | 2.47590625 |
86 | pentose-phosphate shunt (GO:0006098) | 2.47438988 |
87 | regulation of extracellular matrix organization (GO:1903053) | 2.46705615 |
88 | glycine transport (GO:0015816) | 2.46453340 |
89 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.42439205 |
90 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.42335612 |
91 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.42016948 |
92 | regulation of ARF protein signal transduction (GO:0032012) | 2.41189711 |
93 | endothelial cell chemotaxis (GO:0035767) | 2.41028841 |
94 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.38667120 |
95 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.38208699 |
96 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.37709953 |
97 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.36361033 |
98 | peptide catabolic process (GO:0043171) | 2.35006248 |
99 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.34883257 |
100 | sequestering of metal ion (GO:0051238) | 2.34200917 |
101 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.34039120 |
102 | response to endoplasmic reticulum stress (GO:0034976) | 2.33751335 |
103 | embryonic process involved in female pregnancy (GO:0060136) | 2.33582196 |
104 | collagen metabolic process (GO:0032963) | 2.33522835 |
105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.31557272 |
106 | endocytic recycling (GO:0032456) | 2.31507825 |
107 | protein hydroxylation (GO:0018126) | 2.31080967 |
108 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.30656944 |
109 | keratan sulfate catabolic process (GO:0042340) | 2.30335321 |
110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.30143905 |
111 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.29487757 |
112 | glucose catabolic process (GO:0006007) | 2.29323352 |
113 | cellular potassium ion homeostasis (GO:0030007) | 2.28038354 |
114 | regulation of defense response to virus by virus (GO:0050690) | 2.27360154 |
115 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.27254514 |
116 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.27227638 |
117 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.26897776 |
118 | fibril organization (GO:0097435) | 2.26135404 |
119 | extracellular matrix disassembly (GO:0022617) | 2.25946069 |
120 | activation of Rac GTPase activity (GO:0032863) | 2.25682680 |
121 | positive regulation of insulin secretion (GO:0032024) | 2.25524637 |
122 | collagen catabolic process (GO:0030574) | 2.24964795 |
123 | regulation of synaptic vesicle transport (GO:1902803) | 2.24324185 |
124 | NADH metabolic process (GO:0006734) | 2.24093533 |
125 | decidualization (GO:0046697) | 2.23811406 |
126 | nerve growth factor signaling pathway (GO:0038180) | 2.23792017 |
127 | succinate metabolic process (GO:0006105) | 2.23720523 |
128 | cortical actin cytoskeleton organization (GO:0030866) | 2.23589738 |
129 | toxin metabolic process (GO:0009404) | 2.23147825 |
130 | maternal placenta development (GO:0001893) | 2.22784299 |
131 | hypotonic response (GO:0006971) | 2.22714052 |
132 | glial cell migration (GO:0008347) | 2.21946477 |
133 | membrane protein ectodomain proteolysis (GO:0006509) | 2.21869904 |
134 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.21757720 |
135 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.21359577 |
136 | angiotensin maturation (GO:0002003) | 2.21341170 |
137 | neuromuscular process controlling posture (GO:0050884) | 2.20927087 |
138 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.20905198 |
139 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.19949355 |
140 | response to thyroid hormone (GO:0097066) | 2.19282585 |
141 | cellular response to glucagon stimulus (GO:0071377) | 2.18861176 |
142 | cerebellar Purkinje cell layer development (GO:0021680) | 2.15652880 |
143 | ER overload response (GO:0006983) | 2.14710261 |
144 | valine metabolic process (GO:0006573) | 2.13259259 |
145 | glutamate secretion (GO:0014047) | 2.12164489 |
146 | potassium ion import (GO:0010107) | 2.11854692 |
147 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.10582207 |
148 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.09454078 |
149 | positive regulation of catecholamine secretion (GO:0033605) | 2.09192700 |
150 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.08840141 |
151 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.07648824 |
152 | response to unfolded protein (GO:0006986) | 2.07198939 |
153 | peptidyl-asparagine modification (GO:0018196) | 2.07007232 |
154 | response to interleukin-15 (GO:0070672) | 2.06911263 |
155 | exocrine pancreas development (GO:0031017) | 2.05938857 |
156 | regulation of T cell tolerance induction (GO:0002664) | 2.05791145 |
157 | regulation of autophagic vacuole assembly (GO:2000785) | 2.05527323 |
158 | positive regulation of peptide secretion (GO:0002793) | 2.04449506 |
159 | protein localization to endosome (GO:0036010) | 2.04063226 |
160 | adhesion of symbiont to host cell (GO:0044650) | 2.03759954 |
161 | virion attachment to host cell (GO:0019062) | 2.03759954 |
162 | positive thymic T cell selection (GO:0045059) | 2.03028734 |
163 | negative regulation of JUN kinase activity (GO:0043508) | 2.01545910 |
164 | oxaloacetate metabolic process (GO:0006107) | 2.01279405 |
165 | thymic T cell selection (GO:0045061) | 2.01054561 |
166 | regulation of insulin secretion (GO:0050796) | 2.00060416 |
167 | Golgi vesicle transport (GO:0048193) | 2.00052700 |
168 | sodium ion export (GO:0071436) | 2.00023906 |
169 | positive regulation of peptide hormone secretion (GO:0090277) | 1.99949274 |
170 | response to dietary excess (GO:0002021) | 1.99822059 |
171 | response to topologically incorrect protein (GO:0035966) | 1.99265181 |
172 | regulation of extracellular matrix disassembly (GO:0010715) | 1.99064459 |
173 | positive regulation of Rap GTPase activity (GO:0032854) | 1.98621842 |
174 | insulin secretion (GO:0030073) | 1.98543894 |
175 | locomotory exploration behavior (GO:0035641) | 1.97925840 |
176 | protein N-linked glycosylation (GO:0006487) | 1.94666651 |
177 | signal complex assembly (GO:0007172) | 1.93928155 |
178 | endocrine pancreas development (GO:0031018) | 1.92608380 |
179 | regulation of gamma-delta T cell activation (GO:0046643) | 1.91712106 |
180 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 1.91441640 |
181 | growth hormone receptor signaling pathway (GO:0060396) | 1.90277722 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.73790858 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85769706 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82358314 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.56622267 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47759001 |
6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.41624635 |
7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.25582688 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.09113663 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.08427948 |
10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.07406308 |
11 | MYC_22102868_ChIP-Seq_BL_Human | 2.05670423 |
12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95398362 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89180481 |
14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86470510 |
15 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.80405461 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80022068 |
17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79305857 |
18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78372385 |
19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75013298 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74801667 |
21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72098774 |
22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69734827 |
23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67184269 |
24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66846131 |
25 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.61393646 |
26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.59166795 |
27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59122621 |
28 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59121728 |
29 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.56935243 |
30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56740083 |
31 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54830173 |
32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54423190 |
33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54099080 |
34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53135254 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52587918 |
36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52209178 |
37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51077018 |
38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49393129 |
39 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.48647482 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46580639 |
41 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.46090507 |
42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45330960 |
43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42947564 |
44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41447943 |
45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41305894 |
46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40429876 |
47 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40076692 |
48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39655244 |
49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38921599 |
50 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38886276 |
51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.36422179 |
52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36140739 |
53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34577142 |
54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34328905 |
55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33824597 |
56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33645516 |
57 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33091500 |
58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32827110 |
59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32351882 |
60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32213079 |
61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31745533 |
62 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31572821 |
63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31411114 |
64 | MYB_26560356_Chip-Seq_TH2_Human | 1.30719605 |
65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30580571 |
66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29673100 |
67 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28518518 |
68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28323712 |
69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28234375 |
70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27834943 |
71 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26809882 |
72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26690302 |
73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25721548 |
74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24819043 |
75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24703943 |
76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24199342 |
77 | * P68_20966046_ChIP-Seq_HELA_Human | 1.24097097 |
78 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23987250 |
79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22941871 |
80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22268454 |
81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21219389 |
82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21129770 |
83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21114552 |
84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19463938 |
85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19317841 |
86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17732201 |
87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17601206 |
88 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16826479 |
89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16100576 |
90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15766836 |
91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15022243 |
92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14918380 |
93 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.14646461 |
94 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13636722 |
95 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13507115 |
96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12646021 |
97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12620267 |
98 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12106136 |
99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11111915 |
100 | * MAF_26560356_Chip-Seq_TH1_Human | 1.10691991 |
101 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.10222389 |
102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09341820 |
103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08747456 |
104 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08107043 |
105 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08040524 |
106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07417612 |
107 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07011442 |
108 | * MAF_26560356_Chip-Seq_TH2_Human | 1.06730258 |
109 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06566111 |
110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06451282 |
111 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.06010292 |
112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05375835 |
113 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04049046 |
114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02991218 |
115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02425983 |
116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02344603 |
117 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02339873 |
118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02240428 |
119 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01981091 |
120 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01344302 |
121 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01228459 |
122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01160805 |
123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01006851 |
124 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99873149 |
125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99223910 |
126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98986878 |
127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98986364 |
128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97818757 |
129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97419117 |
130 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.96477642 |
131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96432596 |
132 | MYB_26560356_Chip-Seq_TH1_Human | 0.95814001 |
133 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94930356 |
134 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94526496 |
135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93921732 |
136 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.93893342 |
137 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93652165 |
138 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93089504 |
139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92941379 |
140 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92312035 |
141 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92224734 |
142 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89209108 |
143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89040261 |
144 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88861332 |
145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87888968 |
146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87888968 |
147 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87597101 |
148 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86349267 |
149 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85792600 |
150 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85572397 |
151 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84371842 |
152 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.83699367 |
153 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82983685 |
154 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82972686 |
155 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82343511 |
156 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81819152 |
157 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80907225 |
158 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80388669 |
159 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.80216068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 4.18953284 |
2 | MP0000013_abnormal_adipose_tissue | 3.67538118 |
3 | MP0002909_abnormal_adrenal_gland | 3.00115278 |
4 | MP0003183_abnormal_peptide_metabolism | 2.82849049 |
5 | MP0005451_abnormal_body_composition | 2.79001017 |
6 | MP0003300_gastrointestinal_ulcer | 2.78434844 |
7 | MP0005058_abnormal_lysosome_morphology | 2.66087667 |
8 | MP0003566_abnormal_cell_adhesion | 2.43521536 |
9 | MP0004272_abnormal_basement_membrane | 2.33839448 |
10 | MP0003279_aneurysm | 2.32721562 |
11 | MP0004859_abnormal_synaptic_plasticity | 2.28077273 |
12 | MP0005257_abnormal_intraocular_pressure | 2.27169438 |
13 | MP0009780_abnormal_chondrocyte_physiolo | 2.16547326 |
14 | MP0002877_abnormal_melanocyte_morpholog | 2.13367321 |
15 | MP0001849_ear_inflammation | 1.94401599 |
16 | MP0010386_abnormal_urinary_bladder | 1.90192590 |
17 | MP0008438_abnormal_cutaneous_collagen | 1.88718207 |
18 | MP0003724_increased_susceptibility_to | 1.87020585 |
19 | MP0003091_abnormal_cell_migration | 1.86895956 |
20 | MP0003191_abnormal_cellular_cholesterol | 1.86316636 |
21 | MP0003172_abnormal_lysosome_physiology | 1.85798722 |
22 | MP0009840_abnormal_foam_cell | 1.83734534 |
23 | MP0008260_abnormal_autophagy | 1.83407408 |
24 | MP0004043_abnormal_pH_regulation | 1.82021532 |
25 | MP0005671_abnormal_response_to | 1.82020198 |
26 | MP0005310_abnormal_salivary_gland | 1.77017361 |
27 | MP0000003_abnormal_adipose_tissue | 1.77009590 |
28 | MP0002693_abnormal_pancreas_physiology | 1.76979641 |
29 | MP0000858_altered_metastatic_potential | 1.75140414 |
30 | MP0003195_calcinosis | 1.74150561 |
31 | MP0000604_amyloidosis | 1.74024070 |
32 | MP0003329_amyloid_beta_deposits | 1.73778115 |
33 | MP0003866_abnormal_defecation | 1.73456754 |
34 | MP0005379_endocrine/exocrine_gland_phen | 1.69999154 |
35 | MP0005076_abnormal_cell_differentiation | 1.69007173 |
36 | MP0002166_altered_tumor_susceptibility | 1.65275239 |
37 | MP0000685_abnormal_immune_system | 1.63392706 |
38 | MP0005275_abnormal_skin_tensile | 1.60975944 |
39 | MP0005023_abnormal_wound_healing | 1.59807246 |
40 | MP0003453_abnormal_keratinocyte_physiol | 1.57375041 |
41 | MP0001765_abnormal_ion_homeostasis | 1.57171264 |
42 | MP0001944_abnormal_pancreas_morphology | 1.54111334 |
43 | MP0005360_urolithiasis | 1.50781605 |
44 | MP0006082_CNS_inflammation | 1.50118625 |
45 | MP0003075_altered_response_to | 1.49714028 |
46 | MP0002822_catalepsy | 1.48278324 |
47 | MP0005365_abnormal_bile_salt | 1.47729126 |
48 | MP0001835_abnormal_antigen_presentation | 1.46930956 |
49 | MP0003045_fibrosis | 1.46861672 |
50 | MP0001756_abnormal_urination | 1.41609277 |
51 | MP0000920_abnormal_myelination | 1.39350984 |
52 | MP0003690_abnormal_glial_cell | 1.38208710 |
53 | MP0002060_abnormal_skin_morphology | 1.38182349 |
54 | MP0001790_abnormal_immune_system | 1.34945511 |
55 | MP0005387_immune_system_phenotype | 1.34945511 |
56 | MP0005503_abnormal_tendon_morphology | 1.34504714 |
57 | MP0001873_stomach_inflammation | 1.32504801 |
58 | MP0005623_abnormal_meninges_morphology | 1.31912991 |
59 | MP0001533_abnormal_skeleton_physiology | 1.31434723 |
60 | MP0000751_myopathy | 1.30237443 |
61 | MP0003436_decreased_susceptibility_to | 1.30011718 |
62 | MP0009643_abnormal_urine_homeostasis | 1.27267599 |
63 | MP0001666_abnormal_nutrient_absorption | 1.26170842 |
64 | MP0009278_abnormal_bone_marrow | 1.25153029 |
65 | MP0000678_abnormal_parathyroid_gland | 1.24618477 |
66 | MP0005000_abnormal_immune_tolerance | 1.24274565 |
67 | MP0003763_abnormal_thymus_physiology | 1.24161699 |
68 | MP0000767_abnormal_smooth_muscle | 1.23473356 |
69 | MP0001542_abnormal_bone_strength | 1.22204773 |
70 | MP0008961_abnormal_basal_metabolism | 1.22059599 |
71 | MP0000343_altered_response_to | 1.20027529 |
72 | MP0002078_abnormal_glucose_homeostasis | 1.19836622 |
73 | MP0002933_joint_inflammation | 1.19556394 |
74 | MP0005409_darkened_coat_color | 1.18257613 |
75 | MP0009384_cardiac_valve_regurgitation | 1.17956261 |
76 | MP0008569_lethality_at_weaning | 1.17306284 |
77 | MP0004185_abnormal_adipocyte_glucose | 1.16673904 |
78 | MP0003635_abnormal_synaptic_transmissio | 1.16291757 |
79 | MP0003448_altered_tumor_morphology | 1.14817088 |
80 | MP0005220_abnormal_exocrine_pancreas | 1.14629342 |
81 | MP0001501_abnormal_sleep_pattern | 1.13474185 |
82 | MP0003633_abnormal_nervous_system | 1.12737688 |
83 | MP0006054_spinal_hemorrhage | 1.10364198 |
84 | MP0010234_abnormal_vibrissa_follicle | 1.08937211 |
85 | MP0004510_myositis | 1.08479944 |
86 | MP0005390_skeleton_phenotype | 1.07497450 |
87 | MP0004947_skin_inflammation | 1.05214953 |
88 | MP0010352_gastrointestinal_tract_polyps | 1.04194755 |
89 | MP0004233_abnormal_muscle_weight | 1.04112014 |
90 | MP0005535_abnormal_body_temperature | 1.04069496 |
91 | MP0005645_abnormal_hypothalamus_physiol | 1.03444695 |
92 | MP0002089_abnormal_postnatal_growth/wei | 1.03307069 |
93 | MP0002064_seizures | 1.02705844 |
94 | MP0010368_abnormal_lymphatic_system | 1.02548796 |
95 | MP0009333_abnormal_splenocyte_physiolog | 1.01578723 |
96 | MP0005464_abnormal_platelet_physiology | 1.01518841 |
97 | MP0001845_abnormal_inflammatory_respons | 0.99417464 |
98 | MP0009785_altered_susceptibility_to | 0.99068054 |
99 | MP0003303_peritoneal_inflammation | 0.98628801 |
100 | MP0003959_abnormal_lean_body | 0.98604629 |
101 | MP0005375_adipose_tissue_phenotype | 0.98541376 |
102 | MP0005636_abnormal_mineral_homeostasis | 0.98382930 |
103 | MP0010329_abnormal_lipoprotein_level | 0.98223925 |
104 | MP0002837_dystrophic_cardiac_calcinosis | 0.97663379 |
105 | MP0004270_analgesia | 0.97399294 |
106 | MP0002118_abnormal_lipid_homeostasis | 0.96189901 |
107 | MP0001348_abnormal_lacrimal_gland | 0.95396408 |
108 | MP0002796_impaired_skin_barrier | 0.95210233 |
109 | MP0005508_abnormal_skeleton_morphology | 0.94873640 |
110 | MP0010155_abnormal_intestine_physiology | 0.94862740 |
111 | MP0002138_abnormal_hepatobiliary_system | 0.94702897 |
112 | MP0000733_abnormal_muscle_development | 0.94566908 |
113 | MP0005025_abnormal_response_to | 0.94423734 |
114 | MP0005083_abnormal_biliary_tract | 0.93955016 |
115 | MP0005165_increased_susceptibility_to | 0.93733615 |
116 | MP0002723_abnormal_immune_serum | 0.93690780 |
117 | MP0002006_tumorigenesis | 0.92992520 |
118 | MP0004130_abnormal_muscle_cell | 0.92942890 |
119 | MP0001958_emphysema | 0.92702451 |
120 | MP0005666_abnormal_adipose_tissue | 0.92351200 |
121 | MP0002998_abnormal_bone_remodeling | 0.91672829 |
122 | MP0001915_intracranial_hemorrhage | 0.91257916 |
123 | MP0002272_abnormal_nervous_system | 0.91240485 |
124 | MP0009745_abnormal_behavioral_response | 0.90955854 |
125 | MP0004858_abnormal_nervous_system | 0.90495321 |
126 | MP0002419_abnormal_innate_immunity | 0.90492567 |
127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90320940 |
128 | MP0001970_abnormal_pain_threshold | 0.90307950 |
129 | MP0001243_abnormal_dermal_layer | 0.89303969 |
130 | MP0002148_abnormal_hypersensitivity_rea | 0.88209045 |
131 | MP0000747_muscle_weakness | 0.88114820 |
132 | MP0003879_abnormal_hair_cell | 0.87741136 |
133 | MP0008469_abnormal_protein_level | 0.87355208 |
134 | MP0000639_abnormal_adrenal_gland | 0.86603249 |
135 | MP0005166_decreased_susceptibility_to | 0.86527426 |
136 | MP0002420_abnormal_adaptive_immunity | 0.86177810 |
137 | MP0000230_abnormal_systemic_arterial | 0.86105389 |
138 | MP0005164_abnormal_response_to | 0.85596018 |
139 | MP0001968_abnormal_touch/_nociception | 0.85350171 |
140 | MP0005332_abnormal_amino_acid | 0.84308929 |
141 | MP0001819_abnormal_immune_cell | 0.84247117 |
142 | MP0003795_abnormal_bone_structure | 0.83637719 |
143 | MP0002139_abnormal_hepatobiliary_system | 0.81094748 |
144 | MP0000681_abnormal_thyroid_gland | 0.80539559 |
145 | MP0003828_pulmonary_edema | 0.80081920 |
146 | MP0005501_abnormal_skin_physiology | 0.80073674 |
147 | MP0005167_abnormal_blood-brain_barrier | 0.79693026 |
148 | MP0002896_abnormal_bone_mineralization | 0.79528469 |
149 | MP0001800_abnormal_humoral_immune | 0.79008931 |
150 | MP0000490_abnormal_crypts_of | 0.74567744 |
151 | MP0003634_abnormal_glial_cell | 0.74388773 |
152 | MP0002254_reproductive_system_inflammat | 0.73627814 |
153 | MP0001216_abnormal_epidermal_layer | 0.72843147 |
154 | MP0000249_abnormal_blood_vessel | 0.71244557 |
155 | MP0005621_abnormal_cell_physiology | 0.70377000 |
156 | MP0005595_abnormal_vascular_smooth | 0.69053059 |
157 | MP0001853_heart_inflammation | 0.68239970 |
158 | MP0000750_abnormal_muscle_regeneration | 0.68108603 |
159 | MP0000759_abnormal_skeletal_muscle | 0.67472925 |
160 | MP0009931_abnormal_skin_appearance | 0.65832580 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 4.87160319 |
2 | Protrusio acetabuli (HP:0003179) | 4.75963919 |
3 | Dysostosis multiplex (HP:0000943) | 4.18212007 |
4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.95569181 |
5 | Vertebral compression fractures (HP:0002953) | 3.70499917 |
6 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.46891695 |
7 | Mucopolysacchariduria (HP:0008155) | 3.46891695 |
8 | Vacuolated lymphocytes (HP:0001922) | 3.24314858 |
9 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.07241925 |
10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.07241925 |
11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.07241925 |
12 | Hypoglycemic seizures (HP:0002173) | 3.06109069 |
13 | Hypoglycemic coma (HP:0001325) | 2.99976757 |
14 | Papilledema (HP:0001085) | 2.94139916 |
15 | Achilles tendon contracture (HP:0001771) | 2.81066472 |
16 | Atrophic scars (HP:0001075) | 2.78415889 |
17 | Increased cerebral lipofuscin (HP:0011813) | 2.74886853 |
18 | Chronic otitis media (HP:0000389) | 2.70765297 |
19 | Fragile skin (HP:0001030) | 2.68635348 |
20 | Supranuclear gaze palsy (HP:0000605) | 2.68234316 |
21 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.67018335 |
22 | Abnormality of the Achilles tendon (HP:0005109) | 2.61762065 |
23 | Increased connective tissue (HP:0009025) | 2.61418355 |
24 | Ankle contracture (HP:0006466) | 2.61049918 |
25 | Retinal atrophy (HP:0001105) | 2.60965507 |
26 | Neurofibrillary tangles (HP:0002185) | 2.57315366 |
27 | Growth hormone excess (HP:0000845) | 2.53138076 |
28 | Blue sclerae (HP:0000592) | 2.52827512 |
29 | Hyperacusis (HP:0010780) | 2.52452514 |
30 | Spinal rigidity (HP:0003306) | 2.48716230 |
31 | Wormian bones (HP:0002645) | 2.47692324 |
32 | Bladder diverticulum (HP:0000015) | 2.46792196 |
33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.44591262 |
34 | Pheochromocytoma (HP:0002666) | 2.44228124 |
35 | Thin bony cortex (HP:0002753) | 2.42806369 |
36 | Distal lower limb amyotrophy (HP:0008944) | 2.40271835 |
37 | Symptomatic seizures (HP:0011145) | 2.38891999 |
38 | Loss of speech (HP:0002371) | 2.38889255 |
39 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.37148481 |
40 | Beaking of vertebral bodies (HP:0004568) | 2.37097426 |
41 | Deep venous thrombosis (HP:0002625) | 2.33536174 |
42 | Hypercortisolism (HP:0001578) | 2.33215816 |
43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.33008707 |
44 | Neuroendocrine neoplasm (HP:0100634) | 2.32211256 |
45 | Ketoacidosis (HP:0001993) | 2.31600853 |
46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31279806 |
47 | Dilatation of the ascending aorta (HP:0005111) | 2.29584806 |
48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29405760 |
49 | Distal lower limb muscle weakness (HP:0009053) | 2.28934918 |
50 | Ulnar bowing (HP:0003031) | 2.28594368 |
51 | Increased CSF protein (HP:0002922) | 2.27409800 |
52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24883516 |
53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24883516 |
54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24883516 |
55 | Abnormality of complement system (HP:0005339) | 2.24364244 |
56 | Hemorrhage of the eye (HP:0011885) | 2.24260549 |
57 | Genu recurvatum (HP:0002816) | 2.23202264 |
58 | Abnormality of the nasal mucosa (HP:0000433) | 2.22593798 |
59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.21748794 |
60 | Abnormality of the intrinsic pathway (HP:0010989) | 2.21696525 |
61 | Recurrent bronchitis (HP:0002837) | 2.21659718 |
62 | Nuclear cataract (HP:0100018) | 2.21609877 |
63 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.21463337 |
64 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.21463337 |
65 | Biconcave vertebral bodies (HP:0004586) | 2.20104622 |
66 | Flat acetabular roof (HP:0003180) | 2.19458942 |
67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.19084483 |
68 | Shallow orbits (HP:0000586) | 2.18649714 |
69 | Aneurysm (HP:0002617) | 2.17667254 |
70 | Progressive neurologic deterioration (HP:0002344) | 2.16355949 |
71 | Axonal loss (HP:0003447) | 2.16319277 |
72 | Broad face (HP:0000283) | 2.14444907 |
73 | Peritonitis (HP:0002586) | 2.13996330 |
74 | Agitation (HP:0000713) | 2.13256834 |
75 | Nasal polyposis (HP:0100582) | 2.13228548 |
76 | Systemic lupus erythematosus (HP:0002725) | 2.11287833 |
77 | Mitral regurgitation (HP:0001653) | 2.11174065 |
78 | Large for gestational age (HP:0001520) | 2.10970181 |
79 | Disproportionate tall stature (HP:0001519) | 2.09172075 |
80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08358574 |
81 | Abnormality of dentin (HP:0010299) | 2.08104854 |
82 | J-shaped sella turcica (HP:0002680) | 2.07197334 |
83 | Striae distensae (HP:0001065) | 2.06564114 |
84 | Menstrual irregularities (HP:0000858) | 2.06103287 |
85 | Visual hallucinations (HP:0002367) | 2.03789905 |
86 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03204622 |
87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00833026 |
88 | Osteolytic defects of the hand bones (HP:0009699) | 2.00833026 |
89 | Oligomenorrhea (HP:0000876) | 2.00493609 |
90 | Abnormality of T cell number (HP:0011839) | 2.00194734 |
91 | Hyperparathyroidism (HP:0000843) | 2.00110002 |
92 | Elbow flexion contracture (HP:0002987) | 1.99392867 |
93 | Short nail (HP:0001799) | 1.99382466 |
94 | Cerebral hemorrhage (HP:0001342) | 1.98454163 |
95 | Type 1 muscle fiber predominance (HP:0003803) | 1.97569876 |
96 | T lymphocytopenia (HP:0005403) | 1.97365448 |
97 | Hand muscle atrophy (HP:0009130) | 1.96922328 |
98 | Cerebral aneurysm (HP:0004944) | 1.95249570 |
99 | Action tremor (HP:0002345) | 1.94218154 |
100 | Hyperglycemia (HP:0003074) | 1.93708579 |
101 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93206574 |
102 | Interstitial pulmonary disease (HP:0006530) | 1.91716176 |
103 | Aortic aneurysm (HP:0004942) | 1.89853558 |
104 | Intention tremor (HP:0002080) | 1.88796883 |
105 | Myocardial infarction (HP:0001658) | 1.88770470 |
106 | Abnormality of the acetabulum (HP:0003170) | 1.88387757 |
107 | Cerebral inclusion bodies (HP:0100314) | 1.88346723 |
108 | Asymmetric septal hypertrophy (HP:0001670) | 1.88161285 |
109 | Decreased circulating renin level (HP:0003351) | 1.87656751 |
110 | Eczematoid dermatitis (HP:0000976) | 1.87587153 |
111 | Myokymia (HP:0002411) | 1.86520151 |
112 | Spondylolisthesis (HP:0003302) | 1.85518107 |
113 | Arterial tortuosity (HP:0005116) | 1.85463145 |
114 | Generalized amyotrophy (HP:0003700) | 1.84979239 |
115 | Protuberant abdomen (HP:0001538) | 1.84585580 |
116 | Cervical subluxation (HP:0003308) | 1.83013118 |
117 | Complement deficiency (HP:0004431) | 1.82671320 |
118 | Cardiomegaly (HP:0001640) | 1.82539763 |
119 | Soft skin (HP:0000977) | 1.82493865 |
120 | Ovoid vertebral bodies (HP:0003300) | 1.82318234 |
121 | Neonatal short-limb short stature (HP:0008921) | 1.82258049 |
122 | Slender build (HP:0001533) | 1.81617383 |
123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.81209170 |
124 | Upper limb amyotrophy (HP:0009129) | 1.81079333 |
125 | Distal upper limb amyotrophy (HP:0007149) | 1.81079333 |
126 | Macroorchidism (HP:0000053) | 1.80734160 |
127 | Fatigue (HP:0012378) | 1.80165656 |
128 | Amyloidosis (HP:0011034) | 1.80148574 |
129 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79667142 |
130 | Joint stiffness (HP:0001387) | 1.78140146 |
131 | Abnormality of macrophages (HP:0004311) | 1.77891352 |
132 | Joint laxity (HP:0001388) | 1.77745380 |
133 | Mitral valve prolapse (HP:0001634) | 1.77546414 |
134 | Hyperextensible skin (HP:0000974) | 1.76993467 |
135 | Abnormality of carpal bone ossification (HP:0006257) | 1.76967122 |
136 | Vascular tortuosity (HP:0004948) | 1.76690636 |
137 | Obstructive sleep apnea (HP:0002870) | 1.76673427 |
138 | Mitral stenosis (HP:0001718) | 1.76514031 |
139 | Nonimmune hydrops fetalis (HP:0001790) | 1.75519149 |
140 | Type II lissencephaly (HP:0007260) | 1.75416029 |
141 | Increased circulating renin level (HP:0000848) | 1.75351361 |
142 | Bone pain (HP:0002653) | 1.75164792 |
143 | Emphysema (HP:0002097) | 1.74782384 |
144 | Hypokalemic alkalosis (HP:0001949) | 1.74591480 |
145 | Broad metatarsal (HP:0001783) | 1.74589460 |
146 | Ketosis (HP:0001946) | 1.74183982 |
147 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74176033 |
148 | Anxiety (HP:0000739) | 1.73900330 |
149 | Coxa vara (HP:0002812) | 1.73035631 |
150 | Natal tooth (HP:0000695) | 1.72753218 |
151 | Depression (HP:0000716) | 1.72627976 |
152 | Atonic seizures (HP:0010819) | 1.72585862 |
153 | Severe short stature (HP:0003510) | 1.72414886 |
154 | Cupped ribs (HP:0000887) | 1.71971281 |
155 | Ankle clonus (HP:0011448) | 1.71549497 |
156 | Aortic dissection (HP:0002647) | 1.70123200 |
157 | Abnormal ossification of hand bones (HP:0005921) | 1.70100558 |
158 | Back pain (HP:0003418) | 1.69087062 |
159 | Adrenal overactivity (HP:0002717) | 1.69021777 |
160 | Stridor (HP:0010307) | 1.68490425 |
161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.68150324 |
162 | Disproportionate short-trunk short stature (HP:0003521) | 1.68139885 |
163 | Thrombocytosis (HP:0001894) | 1.67904855 |
164 | Polycythemia (HP:0001901) | 1.67058502 |
165 | Autoimmune hemolytic anemia (HP:0001890) | 1.66612905 |
166 | Epiphyseal dysplasia (HP:0002656) | 1.63113516 |
167 | Late onset (HP:0003584) | 1.62708987 |
168 | Enlarged penis (HP:0000040) | 1.62498434 |
169 | Abnormal tarsal ossification (HP:0008369) | 1.60703675 |
170 | Sensorimotor neuropathy (HP:0007141) | 1.60160033 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 3.19492696 |
2 | PRPF4B | 2.84403950 |
3 | ERN1 | 2.79087719 |
4 | TRIB3 | 2.64166861 |
5 | SMG1 | 2.54473167 |
6 | ICK | 2.36317634 |
7 | INSRR | 2.27578421 |
8 | CAMKK2 | 2.25964055 |
9 | NME2 | 2.11379909 |
10 | PRKD3 | 2.04677332 |
11 | ZAP70 | 2.01982852 |
12 | TTN | 1.98181693 |
13 | EPHA2 | 1.96549585 |
14 | NTRK1 | 1.95463043 |
15 | PIK3CG | 1.94666672 |
16 | FGFR4 | 1.94157019 |
17 | MAP3K2 | 1.93862128 |
18 | TXK | 1.93174724 |
19 | EPHB1 | 1.92309155 |
20 | MAPK15 | 1.92073518 |
21 | MAP4K1 | 1.89979653 |
22 | PRKCH | 1.86524164 |
23 | TAOK3 | 1.84986434 |
24 | JAK1 | 1.80440049 |
25 | EEF2K | 1.77266203 |
26 | JAK3 | 1.71127336 |
27 | WNK4 | 1.70496658 |
28 | TAOK2 | 1.69642404 |
29 | DDR2 | 1.66281498 |
30 | SCYL2 | 1.64567162 |
31 | ARAF | 1.60559759 |
32 | CAMKK1 | 1.60410461 |
33 | ITK | 1.56869092 |
34 | KSR2 | 1.52795922 |
35 | FRK | 1.52037133 |
36 | PAK4 | 1.51515338 |
37 | PIM2 | 1.47639252 |
38 | LMTK2 | 1.44640333 |
39 | CDK12 | 1.44191250 |
40 | MAP3K11 | 1.43281970 |
41 | MAP2K3 | 1.43055924 |
42 | MAP3K3 | 1.39558967 |
43 | TYK2 | 1.36790582 |
44 | NTRK3 | 1.35697837 |
45 | MAP3K13 | 1.35118485 |
46 | MST1R | 1.33913729 |
47 | MAP3K1 | 1.33506259 |
48 | CDC42BPA | 1.33220342 |
49 | HIPK2 | 1.30082574 |
50 | CDK19 | 1.28775642 |
51 | TBK1 | 1.21771905 |
52 | PRKD2 | 1.20560250 |
53 | BCKDK | 1.18174807 |
54 | JAK2 | 1.16406693 |
55 | PKN2 | 1.12498115 |
56 | FLT3 | 1.12313245 |
57 | RIPK1 | 1.11967430 |
58 | LATS2 | 1.07424835 |
59 | EPHB2 | 1.06996491 |
60 | UHMK1 | 1.06936569 |
61 | RET | 1.05674027 |
62 | EPHA3 | 1.05539558 |
63 | MOS | 1.04809296 |
64 | WNK3 | 1.04773007 |
65 | PTK6 | 1.04490806 |
66 | IKBKE | 1.03843938 |
67 | LRRK2 | 0.99795460 |
68 | SIK1 | 0.98920664 |
69 | DAPK2 | 0.98920460 |
70 | TGFBR2 | 0.97286894 |
71 | PDK1 | 0.95785145 |
72 | STK39 | 0.94110885 |
73 | TEC | 0.93199924 |
74 | MAP3K9 | 0.90273308 |
75 | MTOR | 0.88090044 |
76 | FES | 0.88085184 |
77 | WNK1 | 0.86380773 |
78 | RPS6KA2 | 0.85723359 |
79 | MAP3K12 | 0.84619929 |
80 | PDPK1 | 0.84252719 |
81 | MARK2 | 0.82423971 |
82 | KDR | 0.79143383 |
83 | PAK2 | 0.78006965 |
84 | ABL2 | 0.74442221 |
85 | PAK6 | 0.74422019 |
86 | PASK | 0.74034406 |
87 | TIE1 | 0.73946767 |
88 | SIK2 | 0.72904498 |
89 | PDGFRA | 0.72300124 |
90 | LCK | 0.71003931 |
91 | FGFR3 | 0.70954117 |
92 | TAOK1 | 0.70028779 |
93 | CDK5 | 0.69257746 |
94 | IRAK4 | 0.69013075 |
95 | MYLK | 0.68818722 |
96 | MAP3K10 | 0.68649938 |
97 | OXSR1 | 0.67805051 |
98 | SYK | 0.67710193 |
99 | BMX | 0.66068978 |
100 | KIT | 0.65408696 |
101 | MAP3K8 | 0.65155595 |
102 | LIMK1 | 0.64603588 |
103 | RPS6KC1 | 0.63393178 |
104 | RPS6KL1 | 0.63393178 |
105 | MAPK11 | 0.63302214 |
106 | MAPKAPK3 | 0.62442002 |
107 | CSK | 0.62306953 |
108 | MAP3K6 | 0.62262647 |
109 | RIPK4 | 0.60755939 |
110 | NEK9 | 0.60665711 |
111 | MET | 0.60242796 |
112 | PRKCQ | 0.60221792 |
113 | TESK1 | 0.60202622 |
114 | BTK | 0.59812779 |
115 | PRKG2 | 0.58540822 |
116 | PTK2 | 0.57535133 |
117 | TNK2 | 0.57096265 |
118 | FER | 0.57073779 |
119 | MAP2K2 | 0.56031339 |
120 | MINK1 | 0.55279854 |
121 | GRK6 | 0.54524725 |
122 | MAPKAPK5 | 0.54229477 |
123 | PAK3 | 0.54028426 |
124 | DAPK1 | 0.53752436 |
125 | TESK2 | 0.53348421 |
126 | GRK5 | 0.51703320 |
127 | SGK223 | 0.51025294 |
128 | SGK494 | 0.51025294 |
129 | PRKD1 | 0.49543589 |
130 | BRAF | 0.49122118 |
131 | IRAK2 | 0.49114378 |
132 | STK38 | 0.48748317 |
133 | DYRK1B | 0.48468395 |
134 | PDGFRB | 0.48321346 |
135 | MST4 | 0.47752256 |
136 | MAP2K1 | 0.47448604 |
137 | DAPK3 | 0.46447547 |
138 | TYRO3 | 0.45766250 |
139 | SGK3 | 0.45648723 |
140 | NLK | 0.45554850 |
141 | MAP3K14 | 0.45487922 |
142 | FYN | 0.45361228 |
143 | BLK | 0.45240443 |
144 | ILK | 0.45121337 |
145 | CDK6 | 0.44685261 |
146 | HCK | 0.41733894 |
147 | MAP3K7 | 0.41476544 |
148 | ALK | 0.40987076 |
149 | CAMK2G | 0.40763109 |
150 | ROCK2 | 0.40207224 |
151 | RPS6KA6 | 0.39109257 |
152 | CAMK1 | 0.38934998 |
153 | MAPKAPK2 | 0.38092367 |
154 | MATK | 0.36681829 |
155 | SIK3 | 0.36355332 |
156 | CSF1R | 0.33862205 |
157 | MAPK7 | 0.33336277 |
158 | MAPK12 | 0.31710109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.00326163 |
2 | Protein export_Homo sapiens_hsa03060 | 2.77068291 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.72487041 |
4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.03620263 |
5 | Lysosome_Homo sapiens_hsa04142 | 2.01417136 |
6 | Insulin secretion_Homo sapiens_hsa04911 | 2.00890242 |
7 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.89378257 |
8 | Bladder cancer_Homo sapiens_hsa05219 | 1.78674001 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77745781 |
10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.77468464 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.77315892 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76108850 |
13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.72990765 |
14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.71315044 |
15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.65326582 |
16 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57426082 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56769604 |
18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54402258 |
19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54260275 |
20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53906687 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51578033 |
22 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.49334060 |
23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.47293051 |
24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45459004 |
25 | Amoebiasis_Homo sapiens_hsa05146 | 1.45105348 |
26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.39962706 |
27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.37804329 |
28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.35193526 |
29 | Focal adhesion_Homo sapiens_hsa04510 | 1.34093965 |
30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32810958 |
31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32260909 |
32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26794905 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25174663 |
34 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.22958510 |
35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22748632 |
36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21268766 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.20502332 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20272382 |
39 | GABAergic synapse_Homo sapiens_hsa04727 | 1.19052248 |
40 | Salmonella infection_Homo sapiens_hsa05132 | 1.17964364 |
41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.16980487 |
42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16898870 |
43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.13120290 |
44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12791390 |
45 | Malaria_Homo sapiens_hsa05144 | 1.12531809 |
46 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11911091 |
47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11294465 |
48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10087590 |
49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08118059 |
50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08097810 |
51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06721901 |
52 | Shigellosis_Homo sapiens_hsa05131 | 1.06371552 |
53 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05529394 |
54 | Circadian entrainment_Homo sapiens_hsa04713 | 1.04163716 |
55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04006503 |
56 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03292660 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 1.02996094 |
58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02971112 |
59 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01110840 |
60 | Apoptosis_Homo sapiens_hsa04210 | 0.95511419 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93262618 |
62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92623599 |
63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92428205 |
64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91495302 |
65 | Renin secretion_Homo sapiens_hsa04924 | 0.91004428 |
66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89840430 |
67 | Salivary secretion_Homo sapiens_hsa04970 | 0.89665392 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89409911 |
69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88371075 |
70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85914172 |
71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84832196 |
72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84763800 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84468184 |
74 | Allograft rejection_Homo sapiens_hsa05330 | 0.84363509 |
75 | Hepatitis B_Homo sapiens_hsa05161 | 0.83828068 |
76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83786505 |
77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83761430 |
78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83401887 |
79 | Endocytosis_Homo sapiens_hsa04144 | 0.83134837 |
80 | Morphine addiction_Homo sapiens_hsa05032 | 0.82667574 |
81 | Prion diseases_Homo sapiens_hsa05020 | 0.82432716 |
82 | Influenza A_Homo sapiens_hsa05164 | 0.82323455 |
83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80348223 |
84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79943471 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.79441006 |
86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79009808 |
87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78724457 |
88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78089730 |
89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77306335 |
90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75925520 |
91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75737041 |
92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75662833 |
93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.74618445 |
94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73240967 |
95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72994765 |
96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72665676 |
97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72585018 |
98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71036372 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70225757 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69402726 |
101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69361387 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69350013 |
103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68062595 |
104 | Glioma_Homo sapiens_hsa05214 | 0.68001522 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66937603 |
106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66183280 |
107 | Pertussis_Homo sapiens_hsa05133 | 0.66070283 |
108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66038017 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65102572 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64796738 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64528932 |
112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64444853 |
113 | Insulin resistance_Homo sapiens_hsa04931 | 0.63023885 |
114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62585998 |
115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62553575 |
116 | Platelet activation_Homo sapiens_hsa04611 | 0.62549672 |
117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62346422 |
118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62018090 |
119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61845336 |
120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61724942 |
121 | Bile secretion_Homo sapiens_hsa04976 | 0.60289854 |
122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60068027 |
123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58808563 |
124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57357637 |
125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57296138 |
126 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57235495 |
127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56913618 |
128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56783763 |
129 | Phagosome_Homo sapiens_hsa04145 | 0.56272366 |
130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55311604 |
131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54333154 |
132 | Prostate cancer_Homo sapiens_hsa05215 | 0.53948087 |
133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51821709 |
134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51182360 |
135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50419026 |
136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50208502 |
137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50128756 |
138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49752039 |
139 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49253766 |
140 | Taste transduction_Homo sapiens_hsa04742 | 0.48527827 |
141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48410555 |
142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48374037 |
143 | Adherens junction_Homo sapiens_hsa04520 | 0.47651705 |
144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47308565 |
145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46745683 |
146 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44304355 |
147 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44104675 |
148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43847647 |
149 | Tuberculosis_Homo sapiens_hsa05152 | 0.43653647 |
150 | Legionellosis_Homo sapiens_hsa05134 | 0.43360853 |
151 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40882987 |
152 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39972003 |
153 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39822290 |
154 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39217922 |
155 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38885923 |
156 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38429416 |
157 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37150857 |
158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36883446 |
159 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35505258 |
160 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34787598 |
161 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34610501 |
162 | Measles_Homo sapiens_hsa05162 | 0.34537604 |
163 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34205486 |